Results 221 to 230 of about 216,694 (240)

Multiple Sclerosis

New England Journal of Medicine, 2000
Claudia Lucchinetti, Brian Weinshenker, Moses Rodríguez   +2 more
exaly  

Rate of Pregnancy-Related Relapse in Multiple Sclerosis

New England Journal of Medicine, 1998
M Hutchinson, T Moreau, C Confavreux
exaly  

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.

The Lancet, 2011
L. Kappos, David K.B. Li, P. Calabresi, P. O'Connor, A. Bar-Or, F. Barkhof, M. Yin, D. Leppert, R. Glanzman, J. Tinbergen, S. Hauser   +10 more
semanticscholar   +1 more source

Axonal Transection in the Lesions of Multiple Sclerosis

New England Journal of Medicine, 1998
Bruce Trapp, Richard Ransohoff, Richard Rudick   +2 more
exaly  

Multiple Sclerosis

New England Journal of Medicine, 2018
Claudia Lucchinetti, Daniel S Reich, Peter A Calabresi   +2 more
exaly  

Multiple Sclerosis — The Plaque and Its Pathogenesis

New England Journal of Medicine, 2006
, Elliot Frohman, Raine Cedric S
exaly  

Remyelination therapies: a new direction and challenge in multiple sclerosis

Nature Reviews Drug Discovery, 2017
V Wee Yong, Jason R Plemel, Wei-Qiao Liu   +2 more
exaly  

Immunopathology of multiple sclerosis

Nature Reviews Immunology, 2015
Manuel A Friese, Calliope Dendrou, Lars Fugger   +2 more
exaly  

Ofatumumab versus Teriflunomide in Multiple Sclerosis

New England Journal of Medicine, 2020
Amit Bar-Or, Jeffrey Cohen, Xavier Montalbán   +2 more
exaly  

Can resistance training impact MRI outcomes in relapsing-remitting multiple sclerosis?

Multiple Sclerosis, 2018
T. Kjølhede, S. Siemonsen, D. Wenzel, J. Stellmann, S. Ringgaard, B. Pedersen, E. Stenager, T. Petersen, K. Vissing, C. Heesen, U. Dalgas   +10 more
semanticscholar   +1 more source